Chronic uveitis and complicated cataract following Aurolab Aqueous Drainage Implant

Treatment of glaucoma is directed towards controlling intraocular pressure (IOP) and the options are many, starting from medical therapy to cyclodestructive surgeries. Drainage devices are a treatment option for glaucoma with a visual prognosis and have a major advantage of long-term success in controlling IOP and better tolerability. The Aurolab Aqueous Drainage Implant (AADI) is devised from a prototype Baerveldt implant. Numerous complications have been reported with the AADI; however, chronic inflammation so far is very rare. In our report, significant uveitis was noted in a patient with primary open-angle glaucoma post failed trabeculectomy after implantation of the AADI, resulting in the formation of annular synechiae and neovascularisation of the iris. There was poor compliance with medications and loss to follow-up owing to COVID-19 restrictions for more than a year. The patient was meticulously managed by intracameral anti-VEGF and synechiae release coupled with cataract extraction and intraocular lens implantation under the cover of steroids.Through this case, we want to emphasise the need for patient compliance towards postoperative medications and, to our knowledge, such dense inflammation following implantation of the AADI has not been reported.